(Q35074843)

6 August 2017

1 reference

3 April 2019

Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer (English)

1 reference

6 August 2017

1 reference

3 April 2019

1 reference

3 April 2019

1 reference

3 April 2019

1 reference

Noguchi M

1

1 reference

6 August 2017

Kikuchi H

series ordinal

2

1 reference

6 August 2017

Ishibashi M

series ordinal

3

1 reference

6 August 2017

Noda S

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

British Journal of Cancer

6 August 2017

27 January 2003

2 references

13 March 2019

3 April 2019

3 references

6 August 2017

13 March 2019

3 April 2019

88

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

195-201

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600715

6 August 2017

exact match

0 references

cites work

Systemic treatment of advanced prostatic cancer: development of a new system for defining response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377050

Prognostic factors in patients with advanced stage prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377050

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377050

Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377050

Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377050

Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377050

Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377050

A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377050

Quantitative bone metastases analysis based on image segmentation.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377050

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377050

Analysis of prognostic factors in men with metastatic prostate cancer. Uro-Oncology Group of Northern Alberta

27 September 2018

1 reference

12 December 2020

Comparison of Phosphatase Isoenzymes PAP and PSA with Bone Scan in Patients with Prostate Carcinoma

1 reference

12 December 2020

Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation

1 reference

12 December 2020

Patterns of bone metastasis and their prognostic significance in patients with carcinoma of the prostate

1 reference

12 December 2020

Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate

1 reference

12 December 2020

Total bone uptake in management of metastatic carcinoma of the prostate

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6600715

1 reference

6 August 2017

1 reference

6 August 2017

1 reference